BMRN logo

BioMarin Pharmaceutical (BMRN)

Profile

Full Name

BioMarin Pharmaceutical Inc.

Ticker Symbol

BMRN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 26, 1999

Indexes

Not included

Website

http://www.biomarin.com

Employees

3040

Key Details

Price

$55.17(+1.98%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$2.85B(+17.97% YoY)

Annual EPS

$2.21(+154.02% YoY)

PE ratio

20.51

Next earnings date

Aug 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $55.17
    BMRN price is $55.17

    30-Day Relative Volume

    1.20
    BMRN 30-day relative volume is 1.20

    Price Performance

    Price Most recent change

    +1.98%
    BMRN price was up +1.98% on Jun 27, 2025

    Price YTD change

    -16.07%
    BMRN price is down -16.07% since January 1st

    Price 1-year change

    -33.93%
    BMRN price is down -33.93% year-on-year

    Price 3-year change

    -35.16%
    BMRN price is down -35.16% over the past 3 years

    Price Range

    Price All-time high

    $151.75
    BMRN price is currently -63.64% below its historical high of $151.75

    Price 3-year low

    $52.93
    BMRN price is currently +4.23% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $10.58B
    BMRN market capitalization is $10.58 billion

    Market cap 3-year change

    -32.79%
    BMRN market capitalization is down -32.79% over the past 3 years

    Market cap All-time high

    $24.01B
    BMRN market capitalization is currently -55.94% below its historical high of $24.01 billion

    Market cap sector rank

    92.88%
    BMRN market capitalization is higher than 92.88% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1%
    BMRN shares outstanding is up +1% year-on-year

    Shares Outstanding 3-Year Change

    +3.67%
    BMRN shares outstanding is up +3.67% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.73
    BMRN beta is 0.73

    200-day SMA

    $65.15
    BMRN price is currently -15.32% below its 200-day simple moving average

    50-day SMA

    $58.49
    BMRN price is currently -5.68% below its 50-day simple moving average

    RSI

    41.72
    BMRN 14-day relative strength index is 41.72

    Volume

    1.20
    BMRN 30-day relative volume is 1.20

    ATR

    $1.36
    BMRN average true range is $1.36

    10-day Historical Volatility

    21.38%
    BMRN 10-day historical volatility is 21.38%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $2.85B
    BMRN annual revenue is $2.85 billion

    Revenue Analysts estimate

    $3.14B
    BMRN annual revenue is currently -9.15% lower than the consensus analysts' forecast

    Revenue 1-year change

    +17.97%
    BMRN annual revenue is up +17.97% year-on-year

    Revenue Sector rank

    88.01%
    BMRN annual revenue is higher than 88.01% of companies in Healthcare sector

    EPS

    EPS

    $2.21
    BMRN annual earnings per share is $2.21

    EPS Analysts estimate

    $4.31
    BMRN annual earnings per share is currently -48.72% lower than the consensus analysts' forecast

    EPS 1-year change

    +154.02%
    BMRN annual earnings per share is up +154.02% year-on-year

    EPS Sector rank

    92.67%
    BMRN annual earnings per share is higher than 92.67% of companies in Healthcare sector

    Profit

    Gross profit

    $2.27B
    BMRN annual gross profit is $2.27 billion

    Gross margin

    79.67%
    BMRN annual gross profit margin is 79.67%

    Operating profit

    $474.21M
    BMRN annual operating income is $474.21 million

    Operating margin

    16.62%
    BMRN annual operating profit margin is 16.62%

    Net income

    $426.86M
    BMRN annual net profit is $426.86 million

    Net margin

    14.96%
    BMRN annual net profit margin is 14.96%

    Expenses

    Total expenses

    $2.38B
    BMRN annual total expenses is $2.38 billion

    Operating expenses

    $1.80B
    BMRN annual total operating expenses is $1.80 billion

    Cost of goods sold

    $580.24M
    BMRN annual cost of goods sold is $580.24 million

    Selling, general & administrative expenses

    $1.01B
    BMRN annual SGA is $1.01 billion

    Depreciation and amortization

    $96.43M
    BMRN annual depreciation & amortization is $96.43 million

    Interest expense

    $12.34M
    BMRN annual interest expense is $12.34 million

    Income tax

    $114.90M
    BMRN annual income tax is $114.90 million

    EBIT & EBITDA

    EBIT

    $554.43M
    BMRN annual earnings before interest & taxes is $554.43 million

    EBITDA

    $650.86M
    BMRN annual EBITDA is $650.86 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $6.99B
    BMRN annual total assets is $6.99 billion

    Non current assets

    $3.76B
    BMRN annual long term assets is $3.76 billion

    Current assets

    $3.23B
    BMRN annual total current assets is $3.23 billion

    Cash and cash equivalents

    $942.84M
    BMRN annual cash & cash equivalents is $942.84 million

    Accounts receivable

    $660.53M
    BMRN annual accounts receivable is $660.53 million

    Inventory

    $1.23B
    BMRN annual inventory is $1.23 billion

    Liabilities

    Total liabilities

    $1.33B
    BMRN annual total liabilities is $1.33 billion

    Long term liabilities

    $723.96M
    BMRN annual total long term liabilities is $723.96 million

    Current liabilities

    $606.99M
    BMRN annual total current liabilities is $606.99 million

    Accounts payable

    $235.40M
    BMRN annual accounts payable is $235.40 million

    Debt

    Total debt

    $602.71M
    BMRN annual total debt is $602.71 million

    Total debt 1-year change

    -45%
    BMRN annual total debt is down -45% year-on-year

    Long term debt

    $595.14M
    BMRN annual long term debt is $595.14 million

    Short term debt

    $7.57M
    BMRN annual short term debt is $7.57 million

    Equity & Capital

    Shareholders equity

    $5.66B
    BMRN annual stockholders equity is $5.66 billion

    Book value

    $5.66B
    BMRN annual book value is $5.66 billion

    Retained earnings

    -$194.69M
    BMRN annual retained earnings is -$194.69 million

    Working capital

    $2.63B
    BMRN annual working capital is $2.63 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $572.84M
    BMRN annual cash flow from operations is $572.84 million

    Cash from operations 1-year change

    +259.69%
    BMRN annual cash flow from operations is up +259.69% year-on-year

    Cash from investing

    $136.49M
    BMRN annual cash flow from investing activities is $136.49 million

    Cash from investing 1-year change

    +222.7%
    BMRN annual cash flow from investing activities is up +222.7% year-on-year

    Cash from financing

    -$526.45M
    BMRN annual cash flow from financing activities is -$526.45 million

    Cash from financing 1-year change

    -2711.17%
    BMRN annual cash flow from financing activities is down -2711.17% year-on-year

    CAPEX

    CAPEX

    $97.42M
    BMRN annual capital expenditures is $97.42 million

    CAPEX 1-year change

    -9.47%
    BMRN annual capital expenditures is down -9.47% year-on-year

    Free Cash Flow

    Free cash flow

    $475.42M
    BMRN annual free cash flow is $475.42 million

    Free cash flow 1-year change

    +820.51%
    BMRN annual free cash flow is up +820.51% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    79.67%
    BMRN annual gross profit margin is 79.67%

    Operating margin

    16.62%
    BMRN annual operating profit margin is 16.62%

    Net margin

    14.96%
    BMRN annual net profit margin is 14.96%

    ROA & ROE

    ROA

    6.17%
    BMRN annual return on assets is 6.17%

    ROE

    8.05%
    BMRN annual return on equity is 8.05%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    20.51
    BMRN price to earnings ratio is 20.51

    PE ratio Sector rank

    42.52%
    BMRN price to earnings ratio is higher than 42.52% of companies in Healthcare sector

    PB Ratio

    PB ratio

    1.83
    BMRN price to book ratio is 1.83

    PB ratio Sector rank

    55.94%
    BMRN price to book ratio is higher than 55.94% of companies in Healthcare sector

    PS Ratio

    PS ratio

    3.59
    BMRN price to sales ratio is 3.59

    PS ratio Sector rank

    56.03%
    BMRN price to sales ratio is higher than 56.03% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $10.13B
    BMRN enterprise value is $10.13 billion

    Enterprise value Sector rank

    91.67%
    BMRN enterprise value is higher than 91.67% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    13.04
    BMRN EV/EBITDA is 13.04

    EV/EBITDA Sector rank

    86.51%
    BMRN EV/EBITDA is higher than 86.51% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.33
    BMRN annual current ratio is 5.33

    Quick ratio

    3.29
    BMRN annual quick ratio is 3.29

    Leverage

    Debt to equity

    0.11
    BMRN annual debt to equity ratio is 0.11

    Interest coverage ratio

    44.93
    BMRN annual interest coverage ratio is 44.93

    Risk & Stability

    Piotroski F-Score

    6
    BMRN piotroski f-score is 6

    Altman Z-Score

    5.85
    BMRN altman z-score is 5.85

    Analyst ratings

    Recent major analysts updates

    May 5, 25 Goldman Sachs
    Buy
    May 2, 25 Citigroup
    Neutral
    Feb 24, 25 Oppenheimer
    Outperform
    Feb 20, 25 UBS
    Buy
    Feb 20, 25 Scotiabank
    Sector Perform
    Feb 20, 25 RBC Capital
    Sector Perform
    Feb 20, 25 Piper Sandler
    Overweight
    Feb 20, 25 Citigroup
    Neutral
    Feb 20, 25 Cantor Fitzgerald
    Overweight
    Feb 20, 25 B of A Securities
    Buy

    Institutional Ownership

    Screeners with BMRN included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for BioMarin Pharmaceutical?
    • Does BioMarin Pharmaceutical pay dividends?
    • What sector is BioMarin Pharmaceutical in?
    • What industry is BioMarin Pharmaceutical in?
    • What country is BioMarin Pharmaceutical based in?
    • When did BioMarin Pharmaceutical go public?
    • Is BioMarin Pharmaceutical in the S&P 500?
    • Is BioMarin Pharmaceutical in the NASDAQ 100?
    • Is BioMarin Pharmaceutical in the Dow Jones?
    • When was BioMarin Pharmaceutical's last earnings report?
    • When does BioMarin Pharmaceutical report earnings?
    • Should I buy BioMarin Pharmaceutical stock now?

    What is the ticker symbol for BioMarin Pharmaceutical?

    The ticker symbol for BioMarin Pharmaceutical is NASDAQ:BMRN

    Does BioMarin Pharmaceutical pay dividends?

    No, BioMarin Pharmaceutical does not pay dividends

    What sector is BioMarin Pharmaceutical in?

    BioMarin Pharmaceutical is in the Healthcare sector

    What industry is BioMarin Pharmaceutical in?

    BioMarin Pharmaceutical is in the Biotechnology industry

    What country is BioMarin Pharmaceutical based in?

    BioMarin Pharmaceutical is headquartered in United States

    When did BioMarin Pharmaceutical go public?

    BioMarin Pharmaceutical's initial public offering (IPO) was on July 26, 1999

    Is BioMarin Pharmaceutical in the S&P 500?

    No, BioMarin Pharmaceutical is not included in the S&P 500 index

    Is BioMarin Pharmaceutical in the NASDAQ 100?

    No, BioMarin Pharmaceutical is not included in the NASDAQ 100 index

    Is BioMarin Pharmaceutical in the Dow Jones?

    No, BioMarin Pharmaceutical is not included in the Dow Jones index

    When was BioMarin Pharmaceutical's last earnings report?

    BioMarin Pharmaceutical's most recent earnings report was on May 1, 2025

    When does BioMarin Pharmaceutical report earnings?

    The next expected earnings date for BioMarin Pharmaceutical is Aug 5, 2025

    Should I buy BioMarin Pharmaceutical stock now?

    As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page